Blue Cross Blue Shield (BCBS) has reached the final stage of a $2.67 billion settlement, nearly two and a half years after an agreement was made with subscribers affected by a class-action lawsuit. Approximately 6 million individuals are expected to receive payments following a legal battle rooted in antitrust allegations.
The lawsuit, initiated in 2013, accused over 35 BCBS plans, including Highmark, of colluding to prevent competition within the healthcare market. As part of the settlement, funds are now being distributed to eligible claimants who filed by the November 2021 deadline. Those who qualify can expect to receive an estimated $333 per claim.
Despite these proceedings, concerns regarding the settlement’s legal and financial aspects persist. The U.S. Supreme Court recently denied an appeal from David Behenna, a class member, who argued that $667 million in legal fees was excessive. Furthermore, the Court rejected another challenge filed by attorneys for Home Depot, who raised concerns that the terms of the settlement could hinder future private litigation against BCBS.
The settlement resolves ongoing litigation, but legal processes are still unfolding for healthcare providers. Providers have until July 29, 2025, to submit claims for their share of a separate $2.8 billion settlement agreement related to similar antitrust violations.
Read more: